Critical care crisis and some recommendations during the COVID-19 epidemic in China

Intensive Care Medicine

Volumn 46, Issue 5, 2020, Pages 837-840

  Xie, Jianfeng ^a   Tong, Zhaohui ^b   Guan, Xiangdong ^c   Du, Bin ^d   Qiu, Haibo ^a   Slutsky, Arthur S ^e  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; CHINA; CORONAVIRUS DISEASE 2019; EARLY INTERVENTION; EARLY WARNING SCORE; EPIDEMIC; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MORTALITY RATE; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; CORONAVIRUS INFECTION; HEALTH CARE PERSONNEL; PANDEMIC; PROTECTIVE EQUIPMENT; VIRUS PNEUMONIA;

CHINA; CORONAVIRUS INFECTIONS; CRITICAL CARE; HEALTH PERSONNEL; HUMANS; PANDEMICS; PERSONAL PROTECTIVE EQUIPMENT; PNEUMONIA, VIRAL;

EID: 85081534615     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-020-05979-7     Document Type: Article

References (13)

1. Li Q, Guan X, Wu P et al (2020) Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 10.1056/NEJMoa2001316
2. Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet. 10.1016/S0140-6736(20)30183-5
3. Bulletin of the National Health Commission of China on the 2019 new coronavirus infection. http://www.nhc.gov.cn/xcs/xxgzbd/gzbd_index.shtml. Accessed 11 Feb 2020
4. Shi CC, Li JG, Hu B et al (2016) A survey of the development of critical medicine in Hubei Province. J Internal Intensive Med 22:19–21
5. Chen N, Zhou M, Dong X et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 10.1016/S0140-6736(20)30211-7
6. Wang D, Hu B, Hu C et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan. China. JAMA. 10.1001/jama.2020.1585
7. Domı´nguez-Cherit G, Lapinsky SE, Macias AE et al (2009) Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 302(17):1880–1887
8. Kumar A, Zarychanski R, Pinto R et al (2009) Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 302(17):1872–1879
9. Drosten C, Seilmaier M, Corman V et al (2013) Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 13(9):745–751
10. Lu R, Zhao X, Li J et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 10.1016/S0140-6736(20)30251-8
11. Wang M, Cao R, Zhang L et al (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 10.1038/s41422-020-0282-0
12. Holshue ML, DeBolt C, Lindquist S et al (2020) First Case of 2019 novel cornavirus in the united states. N Engl J Med. 10.1056/NEJMoa2001191
13. Clinical management of severe acute respiratory infection when Novel coronavirus (2019-nCoV) infection is suspected: Interim Guidance